Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
Halozyme CEO targets new deals as IRA uncertainty subsides
As drug developers gain a better grasp of the IRA’s impact, Halozyme has seen a ramp-up in deal discussions over its subcutaneous platform.
Angus Liuu
Oct 14, 2025 9:40am
Germany's LTS boosts US drug delivery CDMO footprint through M&A
Oct 13, 2025 10:49am
Vifor to cut 55 staffers in Pa. amid CSL downsizing effort
Oct 8, 2025 10:45am
Novo-KBP, Takeda, Enhertu—Fierce Pharma Asia
Oct 2, 2025 4:02pm
Fierce Biotech
Novo vs. KBP Chapter 3: Fraud or due diligence slipup?
Oct 2, 2025 3:00am
Halozyme buys Elektrofi for up to $900M
Oct 1, 2025 2:36pm
